Navigation Links
GW researcher receives more than $1 million in grants to study epigenetics of pancreatic cancer
Date:7/1/2014

WASHINGTON (July 1, 2014) Alexandros Tzatsos, M.D., Ph.D., assistant professor of anatomy and regenerative biology at the George Washington University School of Medicine and Health Sciences, was awarded over one million dollars in grants from the National Institutes of Health to study the molecular foundations of pancreatic cancer.

In May, Tzatsos received an R00 award for $706K, which is the second phase of a National Cancer Institute K99/R00 Howard Temin Pathway to Independence Award in Cancer Research a grant meant to aid young researchers in setting up independent research labs. This grant will fund his research project, "The Role of Epigenetic Regulators in Pancreatic Cancer." In February, Tzatsos also received a $374K R21 award to fund his research project, "Elucidating and Targeting Epigenetic Oncogenic Networks in Pancreatic Cancer."

According to the American Cancer Society, pancreatic cancer is the fourth leading cause of cancer-related death in the U.S. Few cases are found early enough for effective treatment. Tzatsos studies the role of a histone demethylase that drives the development of pancreatic cancer and he has generated new genetically engineered mouse models to address the role of this epigenetic regulator in vivo.

"We propose to use those mouse models to study pancreatic cancer and develop targeted therapies in a preclinical level," said Tzatsos. "This could be key to understand the molecular pathology of pancreatic cancer and develop better therapies."


'/>"/>

Contact: Lisa Anderson
lisama2@gwu.edu
202-994-3121
George Washington University
Source:Eurekalert

Page: 1

Related medicine news :

1. Mayo Clinic researchers reveal treasure trove of genes key to kidney cancer
2. Researchers seek to tackle transplant tolerance using patients own T cells
3. Moffitt researchers develop new way to combat drug resistance for melanoma patients
4. Researchers estimate 5.8 million A&E visits occur after patients unable to see a GP
5. Researchers conduct comprehensive review of treatments for depression in cancer patients
6. Miriam Hospital researchers develop app focused on making obese adults less sedentary
7. Researchers home in on way to predict aggressiveness of oral cancer
8. Researchers call for patients who receive home nutritional care to have emergency plans
9. Chronic brain damage not as prevalent in NFL players, say researchers
10. Researchers treat incarceration as a disease epidemic, discover small changes help
11. Researchers publish one of the longest longitudinal studies of cognition in MS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... September 22, 2017 , ... First Choice ... celebrating the one year anniversary of its Houston-Fallbrook facility. , “We are ... Facility Medical Director of First Choice Emergency Room Houston-Fallbrook. “It has been a ...
(Date:9/22/2017)... ... ... “Letters From Home”: a moving compilation of letters that remind readers of the ... is the creation of published author, John Allred, a passionate leader of ministry to ... who has traveled and ministered on four continents. , “It is my hope and ...
(Date:9/21/2017)... , ... September 21, 2017 , ... With ProSlideshow Portrait ... and easy to do. Users can select from up to two layers of subject ... click of a mouse all within Final Cut Pro X. , With ...
(Date:9/21/2017)... , ... September 21, 2017 , ... ... learn with Infinity Behavioral Health Services for professionals in the addiction treatment industry ... Payer Audit . , Insurance companies and state and federal governments are ...
(Date:9/21/2017)... ... September 21, 2017 , ... Bill Howe Plumbing’s mission is to create an ... to the community. For over 37 years, they have operated with their mission at ... in San Diego. They were chosen as the Best San Diego plumber in ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ... on the development of oral drug delivery systems, announced ... the U.S. Food and Drug Administration (FDA) regarding ORMD-0801, ... At the meeting, the FDA gave ... ORMD-0801, would be a Biologics License Application (BLA).  Such ...
(Date:8/29/2017)... , Aug. 29, 2017 ivWatch, LLC, the leading provider ... infiltrations, announced it has been awarded an Innovative Technology contract from ... the country. ... device to aid in the early detection of peripheral IV infiltration ... The Innovative Technology contract ...
Breaking Medicine Technology: